BioSpace News Archive

Kermode Biotechnologies, Inc., a privately-held US-based biotechnology company focused on animal health, announced that it is actively engaged in discovery to identify the mode of transmission and replication for the African Swine Fever (ASF) virus.

Award recognizes state-of-the-art projects utilizing new, innovative technologies to improve the quality of products, to reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery

Immuneering Corporation (“Immuneering”) today announced the addition of Laurie Keating to its board of directors.

Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that Ryo Kubota, MD, PhD, Chairman, President and CEO of Kubota Vision Inc., will speak at the Ophthalmology Innovation Summit (OIS) Myopia Innovation Showcase on April 29, 2021 in the U.S.

Coya Therapeutics, Inc., (Coya), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous regulatory T cells (Tregs) and Treg-derived exosome therapeutics for neurodegenerative and autoimmune diseases, today announced that Howard Berman, Ph.D., Chief Executive Officer of Coya Therapeutics, will present a corporate overview at the B. Riley Securities’ Virtual Neuroscience Conference being held on April 28 - 29, 2021

BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it will report its financial results for the quarter and year ended December 31, 2020 on Friday, April 30, 2021. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30am Eastern Time.

TG4001 - Regulatory clearance received for randomized Phase II trial – First patient expected to be enrolled in 2Q 2021 TG6002 - Initial Phase I data provides clinical proof of concept for the intravenous administration of Transgene’s double deleted VV cop TK-RR- patented virus backbone, the basis of the Invir.IO™ oncolytic virus backbone

Next Science Limited (ASX:NXS) (Next Science / Company) is pleased to announce that it has received a section 510(k) clearance from the Food and Drug Administration (FDA) for the sale of XPERIENCE No Rinse Antimicrobial Solution as a medical device in the United States. Sales of XPERIENCE in the US will commence immediately.

Renzo DiCarlo, CEO of BioPharma Services Inc. was proud to be invited to appear as a witness before the House of Commons’ Standing Committee on International Trade, in view of its study entitled Canada’s International Trade and Investment Policy: Selected Considerations Concerning COVID-19 Vaccines . As a London School of Economics (LSE) alumnus in stakeholder theory research with 25 years of experience in Pharmace

Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced it will present the results of a multicenter, phase 2, laboratory classroom study which evaluated the safety and efficacy of its investigational dextroamphetamine transdermal system (“ATS”) in over 100 pediatric patients (ages 6-17 years) with ADHD at the 2021 virtual American Psychiatric Association